Accessories to the crime: functions of cells recruited to the tumor microenvironment, Cancer Cell, vol.21, pp.309-331, 2012. ,
The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review, Urol Oncol, vol.35, pp.135-176, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01792761
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, vol.30, pp.1073-81, 2009. ,
The role of CXC chemokines and their receptors in cancer, Cancer Lett, vol.267, pp.226-270, 2008. ,
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, vol.6, pp.447-58, 2004. ,
Interleukin-8 in cancer pathogenesis, treatment and follow-up, Cancer Treat Rev, vol.60, pp.24-31, 2017. ,
Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways, Cancer Sci, vol.107, pp.391-398, 2016. ,
The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer, Biochim Biophys Acta, vol.1825, pp.117-146, 2012. ,
The expression and role of CXC chemokines in colorectal cancer, Cytokine Growth Factor Rev, vol.22, pp.345-58, 2011. ,
The role of chemokines in melanoma tumor growth and metastasis, J Invest Dermatol, vol.118, pp.915-937, 2002. ,
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas, Br J Cancer, vol.117, pp.947-53, 2017. ,
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma, Cancer Res, vol.74, pp.873-83, 2014. ,
IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway, Oncotarget, vol.7, pp.61820-61851, 2016. ,
Down-regulation of CXCL5 inhibits squamous carcinogenesis, Cancer Res, vol.66, pp.4279-84, 2006. ,
HIF-alpha/MIF and NF-kappaB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC, Neoplasia, vol.16, pp.168-79, 2014. ,
CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma, Eur J Cancer, vol.51, pp.1953-61, 2015. ,
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases, Theranostics, vol.7, pp.1543-88, 2017. ,
The Protein Data Bank, Nucleic Acids Res, vol.28, pp.235-277, 2000. ,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J Comput Chem, vol.30, pp.2785-91, 2009. ,
LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters, J Chem Inf Model, vol.45, pp.160-169, 2005. ,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J Comput Chem, vol.31, pp.455-61, 2010. ,
Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment, Eur J Cancer Clin Oncol, vol.24, pp.1445-55, 1988. ,
The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma, PLoS ONE, vol.9, p.89449, 2014. ,
Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells, Oncotarget, vol.2, pp.874-85, 2011. ,
Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells, Anticancer Res, vol.29, pp.2993-2999, 2009. ,
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, p.1, 2013. ,
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, pp.401-405, 2012. ,
Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction, J Biol Chem, vol.269, pp.19343-19351, 1994. ,
Internalization of G-protein-coupled receptors: Implication in receptor function, physiology and diseases, Best Pract Res Clin Endocrinol Metab, vol.32, pp.83-91, 2018. ,
Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2, J Pharmacol Exp Ther, vol.362, pp.338-384, 2017. ,
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines, Oncogene, vol.31, pp.1683-94, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00824206
Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux, Autophagy, vol.11, pp.1891-904, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02108861
Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma, Oncogenesis, vol.6, p.354, 2017. ,
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas, Cancer Res, vol.77, pp.1212-1238, 2017. ,
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma, N Engl J Med, vol.378, pp.1277-90, 2018. ,
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma, Cancer Treat Rev, vol.70, pp.127-164, 2018. ,
The chemoradiation paradigm in head and neck cancer, Nat Clin Pract Oncol, vol.4, pp.156-71, 2007. ,
Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, vol.68, pp.394-424, 2018. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-74, 2011. ,
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma, N Engl J Med, vol.373, pp.1803-1816, 2015. ,
Immunotherapy for Head and Neck Squamous Cell Carcinoma, Curr Oncol Rep, vol.20, p.22, 2018. ,
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma, Ann Oncol, vol.28, pp.1605-1616, 2017. ,
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1beta, IL8, CXCL5, and Mip-1alpha, Clin Cancer Res, vol.23, pp.2346-55, 2017. ,